X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Clinical Trials News - 24/Jun 23:06

Promising results from the Phase 2 study of novel extended-release ketamine tablets (R-107) for Treatment-Resistant Depression accepted for publication by Nature Medicine

AUCKLAND, New Zealand, June 24, 2024. Douglas Pharmaceuticals, New Zealand's largest pharmaceutical company, is pleased to announce that results from their recent trial, "Randomised Placebo-Controlled Phase 2 Study of Extended-Release Ketamine...

Articles similaires

Prolonged-Release Ketamine Tablets: Potential Cure for Severe Depression

medindia.net - 25/Jun 14:35

A novel tablet formulation of ketamine has demonstrated potential in the treatment of severe depression, providing a possible substitute for the...

Sorry! Image not available at this time

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

drugs.com - 22/Jun 04:06

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 22, 2024 – Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b,...

Sorry! Image not available at this time

New ketamine pill shows promise for treating severe depression

knowridge.com - 01/Jul 10:07

A new pill that releases ketamine slowly over time could treat severe depression without causing the psychedelic side effects often associated with...

Prolonged-Release Ketamine Tablets: Potential Cure for Severe Depression

medindia.net - 25/Jun 14:35

Prolonged-release ketamine tablet has potential as affordable and convenient treatment for severe depression and with minimal side effects

Sorry! Image not available at this time

Slow-Release Ketamine Pill Eases Depression: Study

drugs.com - 25/Jun 14:06

TUESDAY, June 25, 2024 -- A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects...

Slow-release ketamine tablets help prevent depression relapses, UK trial finds

theguardian.com - 24/Jun 15:00

71% of patients found to experience a relapse compared with 43% who received the pills twice a week

Successful trial for new colorectal cancer treatment

oncologynews.com.au - 21/Jun 15:31

Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal cancer, also known as...

Sorry! Image not available at this time

Contact Energy Picks Tesla Megapacks to Power 100MW Battery in New Zealand

driveteslacanada.ca - 01/Jul 14:33

New Zealand’s Contact Energy has announced plans to build a 100-megawatt (MW) grid-scale battery at Glenbrook, near Auckland, New Zealand, powered...

Air New Zealand flight from Auckland to Shanghai diverted after engine issue

nzherald.co.nz - 01/Jul 21:17

An engine using more oil than usual forced the plane to turn around for Auckland.